Arvinas
Leading the way in targeted protein degradation therapeutics
305 employees · est. 2013 · New Haven, United States
Arvinas is the older company (2013 vs 2019); Arvinas is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Arvinas | Cyrus Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2019 |
| Headquarters | ||
| Headquarters | New Haven, United States | Seoul, Korea South |
| Employees | ||
| Employees | 305 larger | 15 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Unknown | Series B |
| Total Funding | ||
| Total Funding | $585.85M | $39.00B |
| Funding Rounds | ||
| Funding Rounds | 6 | 2 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Protein Degradation, Therapeutics, Clinical-stage, Disease Treatment, PROTAC® Discovery Engine Platform, Proteolysis Targeting Chimeras, Metastatic Castrate-resistant Prostate Cancer, Locally Advanced Breast Cancer, Metastatic ER+/HER2- Breast Cancer, Drug Discovery, Autoimmune Diseases, Rare Diseases, Cancer Therapy, Preclinical Pipeline | Medicines, Innovation, Chronic Diseases, Life-threatening Diseases, Small Molecule Drugs, Chemical Modalities, Protein Degraders, Drug Discovery, Therapeutics, Biopharmaceuticals |
| Website | ||
| Website | arvinas.com | cyrustx.com |
About Arvinas
Arvinas is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in the United States. The company is committed to developing targeted protein degradation therapeutics with the aim of improving the lives of patients suffering from debilitating and life-threatening diseases. Th...
About Cyrus Therapeutics
Cyrus Therapeutics is a promising biotechnology company that was founded in 2019 in South Korea. The company's mission, 'drugging the undruggable targets,' emphasizes its dedication to developing innovative medicines for chronic or life-threatening diseases with high unmet needs. Utilizing small mol...
We will tell you when either one moves
BounceWatch watches Arvinas and Cyrus Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Arvinas and Cyrus Therapeutics — by email.
Frequently Asked Questions
Compare Arvinas with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Arvinas on 9 Jun 2026, and Cyrus Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.